Generic and Brand Names: AICAR, which is also known as Acadesine or 5-Aminoimidazole-4-Carboxamide Ribonucleotide. There are currently no approved brands for the use of this drug for its therapeutic purposes. AICAR is primarily seen as an investigational agent, therefore the drug is referred to by its generic name by professionals working in labs on preclinical studies.
Drug classification: AICAR belongs to the class of AMPK Activator, Purine Nucleoside Analog Metabolic Modulator, Cellular Energy Homeostasis Regulator and Insulin Sensitizing Research Agent
Chemical information: AICAR is a synthetic purine nucleoside analogue that has the following molecular formula, C9H14N4O5, and molecular weight 258.23 Da. This drug is a ribonucleotide derivative that works as a pro-drug metabolized in a cell into ZMP. Like the other amino acid peptides, AICAR exhibits great water solubility, permeability and biochemical stability in physiological conditions.
Mechanism of action
- Activation of receptors and enzymes
The biological mechanism of AICAR action is based on indirect allosteric activation of the Adenosine Monophosphate-Activated Protein Kinase (AMPK) by this agent. After intracellular conversion of AICAR into ZMP, ZMP imitates the AMP and binds to the regulatory domain thus activating the kinase. Due to this mechanism, the agent does not interact with GLP-1, GIP and melanocortin and does not bind to other metabolic receptors.1.2 Metabolic and Physiological Effects
The activation of AMPK that occurs because of AICAR is thought to improve overall human metabolism, which is important for research involving metabolism-related disorders. The stimulation effects include an increase in insulin sensitivity and glucose uptake in muscles and fat tissues, as well as a decrease in glucose production by the liver, which leads to the stabilization of glucose levels in the blood leading to improvements in the symptoms of type 2 diabetes. This compound enhances the process of fat burning, prevents fat production, and contributes to increased total energy expenses of the organism, which helps to control the weight problems of a person. What is more, the compound can reduce metabolic abnormalities caused by intermittent hypoxia.
- Indications and Usage (Research Only)
The use of AICAR is limited to scientific research only, as there is no permission for its application in medical procedures.
Type 2 Diabetes Mellitus Research: It is used in the experiments concerning insulin resistance, impaired glucose tolerance, and liver metabolism in terms of the effects of AMPK.
Chronic Weight Management Research: It is applied in studies involving obesity in terms of fat burning process and energy balance regulation.
Obstructive Sleep Apnea Research: Aicarm use in research helps improve metabolicCore Energy Metabolism Study: It is considered a highly recommended research method in studying the AMPK biochemical pathway, cellular energy homeostasis and the mechanisms of metabolic adaptations during physical exercise.
- Dosage and administration (research laboratory standards)
3.1 Routes and frequencies
AICAR Peptide is for research use only and academic experimental purposes. It is not registered as a pharmaceutical drug, dietary supplement or an over-the-counter medicine and has no clinical use approval from the FDA, EMA or other regional medical regulatory body. The product cannot be used for human clinical diagnosis, treatment of disease, oral or intravenous administration as well as commercial off-label usage. All of the product details and research data is academic in nature and not intended as medical advice or to be construed as therapeutic claims. Local laws, institutional laboratory-management requirements, and ethical-research standards must be followed by all purchasers and researchers. 무단 불법 사용시 당사는 책임을 지지 않습니다., 제품의 부적절한 작동 또는 비연구 용도.
Powerae.com










